These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 11533704)

  • 1. Predicting the unpredictable: transmission of drug-resistant HIV.
    Blower SM; Aschenbach AN; Gershengorn HB; Kahn JO
    Nat Med; 2001 Sep; 7(9):1016-20. PubMed ID: 11533704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolutionary dynamics of complex networks of HIV drug-resistant strains: the case of San Francisco.
    Smith RJ; Okano JT; Kahn JS; Bodine EN; Blower S
    Science; 2010 Feb; 327(5966):697-701. PubMed ID: 20075214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Your next nightmare: 28% of new HIV cases may be drug-resistant.
    AIDS Alert; 1999 Dec; 14(12):133-7. PubMed ID: 11366987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug resistance. Navigating resistance pathways.
    Kuritzkes D
    AIDS Read; 2002 Sep; 12(9):395-400, 407. PubMed ID: 12402803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and determinants of transmitted antiretroviral drug resistance in HIV-1 infection.
    Booth CL; Geretti AM
    J Antimicrob Chemother; 2007 Jun; 59(6):1047-56. PubMed ID: 17449483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Worldwide transmission of drug-resistant HIV.
    Wensing AM; Boucher CA
    AIDS Rev; 2003; 5(3):140-55. PubMed ID: 14598563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changing transmission fitness of drug-resistant human immunodeficiency virus against a background of evolving antiretroviral therapy.
    Murray JM
    J Infect Dis; 2003 Oct; 188(8):1258; author reply 1258-9. PubMed ID: 14551898
    [No Abstract]   [Full Text] [Related]  

  • 9. Transmission of HIV-1 drug resistance.
    Tang JW; Pillay D
    J Clin Virol; 2004 May; 30(1):1-10. PubMed ID: 15072747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transmission fitness of drug-resistant human immunodeficiency virus and the prevalence of resistance in the antiretroviral-treated population.
    Leigh Brown AJ; Frost SD; Mathews WC; Dawson K; Hellmann NS; Daar ES; Richman DD; Little SJ
    J Infect Dis; 2003 Feb; 187(4):683-6. PubMed ID: 12599087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotypic resistance tests for the clinical management of patients with primary HIV infection.
    Narciso P; Lazzarin A
    Scand J Infect Dis Suppl; 2003; 106():66-70. PubMed ID: 15000588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The emergence and epidemiology of resistance in the nucleoside-experienced HIV-infected population.
    Pillay D
    Antivir Ther; 2001; 6 Suppl 3():15-24. PubMed ID: 11678470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current patterns in the epidemiology of primary HIV drug resistance in North America and Europe.
    Pillay D
    Antivir Ther; 2004 Oct; 9(5):695-702. PubMed ID: 15535406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of a drug-resistant human immunodeficiency virus variant in a newly infected heterosexual couple.
    Romano L; Venturi G; Vivarelli A; Galli L; Zazzi M
    Clin Infect Dis; 2002 Jan; 34(1):116-7. PubMed ID: 11731954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiretroviral recommendations may influence the rate of transmission of drug-resistant HIV type 1.
    de Mendoza C; Rodriguez C; Eiros JM; Colomina J; Garcia F; Leiva P; Torre-Cisneros J; Aguero J; Pedreira J; Viciana I; Corral A; del Romero J; Ortiz de Lejarazu R; Soriano V
    Clin Infect Dis; 2005 Jul; 41(2):227-32. PubMed ID: 15983920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of HIV-1 drug resistance during antiretroviral treatment.
    Rong L; Feng Z; Perelson AS
    Bull Math Biol; 2007 Aug; 69(6):2027-60. PubMed ID: 17450401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A decrease in drug resistance levels of the HIV epidemic can be bad news.
    Sánchez MS; Grant RM; Porco TC; Gross KL; Getz WM
    Bull Math Biol; 2005 Jul; 67(4):761-82. PubMed ID: 15893552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of differential selection of HIV-1 variants carrying drug-resistant mutations in seroconverters.
    Corvasce S; Violin M; Romano L; Razzolini F; Vicenti I; Galli A; Duca P; Caramma I; Balotta C; Zazzi M
    Antivir Ther; 2006; 11(3):329-34. PubMed ID: 16759049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidrug-resistant HIV-1.
    Tayloe D
    Clin Infect Dis; 2004 May; 38(10):1507; author reply 1507. PubMed ID: 15156500
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug-resistant HIV: predicting the future.
    Laurence J
    AIDS Read; 2001 Oct; 11(10):485-6. PubMed ID: 11708079
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.